Literature DB >> 32409590

Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses.

Esther Molina-Montes1,2, Claudia Coscia1,2, Paulina Gómez-Rubio1,2, Alba Fernández1, Rianne Boenink1, Marta Rava1, Mirari Márquez1,2, Xavier Molero3,4, Matthias Löhr5, Linda Sharp6,7, Christoph W Michalski8,9, Antoni Farré10, José Perea11,12, Michael O'Rorke13,14, William Greenhalf15, Mar Iglesias2,16, Adonina Tardón17,18, Thomas M Gress19, Victor M Barberá20, Tatjana Crnogorac-Jurcevic21, Luis Muñoz-Bellvís22, J Enrique Dominguez-Muñoz23, Harald Renz24, Joaquim Balcells4,25, Eithne Costello15, Lucas Ilzarbe26, Jörg Kleeff8,9, Bo Kong8, Josefina Mora10, Damian O'Driscoll6,7, Ignasi Poves27, Aldo Scarpa28, Jingru Yu29, Manuel Hidalgo30,31, Rita T Lawlor28, Weimin Ye29, Alfredo Carrato2,32, Francisco X Real2,33, Núria Malats34,2.   

Abstract

OBJECTIVES: To characterise the association between type 2 diabetes mellitus (T2DM) subtypes (new-onset T2DM (NODM) or long-standing T2DM (LSDM)) and pancreatic cancer (PC) risk, to explore the direction of causation through Mendelian randomisation (MR) analysis and to assess the mediation role of body mass index (BMI).
DESIGN: Information about T2DM and related factors was collected from 2018 PC cases and 1540 controls from the PanGenEU (European Study into Digestive Illnesses and Genetics) study. A subset of PC cases and controls had glycated haemoglobin, C-peptide and genotype data. Multivariate logistic regression models were applied to derive ORs and 95% CIs. T2DM and PC-related single nucleotide polymorphism (SNP) were used as instrumental variables (IVs) in bidirectional MR analysis to test for two-way causal associations between PC, NODM and LSDM. Indirect and direct effects of the BMI-T2DM-PC association were further explored using mediation analysis.
RESULTS: T2DM was associated with an increased PC risk when compared with non-T2DM (OR=2.50; 95% CI: 2.05 to 3.05), the risk being greater for NODM (OR=6.39; 95% CI: 4.18 to 9.78) and insulin users (OR=3.69; 95% CI: 2.80 to 4.86). The causal association between T2DM (57-SNP IV) and PC was not statistically significant (ORLSDM=1.08, 95% CI: 0.86 to 1.29, ORNODM=1.06, 95% CI: 0.95 to 1.17). In contrast, there was a causal association between PC (40-SNP IV) and NODM (OR=2.85; 95% CI: 2.04 to 3.98), although genetic pleiotropy was present (MR-Egger: p value=0.03). Potential mediating effects of BMI (125-SNPs as IV), particularly in terms of weight loss, were evidenced on the NODM-PC association (indirect effect for BMI in previous years=0.55).
CONCLUSION: Findings of this study do not support a causal effect of LSDM on PC, but suggest that PC causes NODM. The interplay between obesity, PC and T2DM is complex. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer epidemiology; diabetes mellitus; obesity; pancreatic cancer

Year:  2020        PMID: 32409590     DOI: 10.1136/gutjnl-2019-319990

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

Review 1.  UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better.

Authors:  Patrick Michl; Matthias Löhr; John P Neoptolemos; Gabriele Capurso; Vinciane Rebours; Nuria Malats; Mathilde Ollivier; Luigi Ricciardiello
Journal:  United European Gastroenterol J       Date:  2021-08-25       Impact factor: 6.866

2.  Dietary Patterns of Insulinemia, Inflammation and Glycemia, and Pancreatic Cancer Risk: Findings from the Women's Health Initiative.

Authors:  Qi Jin; Phil A Hart; Ni Shi; Joshua J Joseph; Macarius Donneyong; Darwin L Conwell; Steven K Clinton; Zobeida Cruz-Monserrate; Theodore M Brasky; Lesley F Tinker; Simin Liu; Aladdin H Shadyab; Cynthia A Thomson; Lihong Qi; Thomas Rohan; Fred K Tabung
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-04-07       Impact factor: 4.254

Review 3.  Pancreas Optical Clearing and 3-D Microscopy in Health and Diabetes.

Authors:  Martha Campbell-Thompson; Shiue-Cheng Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-26       Impact factor: 6.055

4.  Single-Cell Transcriptomics Reveals a Conserved Metaplasia Program in Pancreatic Injury.

Authors:  Zhibo Ma; Nikki K Lytle; Bob Chen; Nidhi Jyotsana; Sammy Weiser Novak; Charles J Cho; Leah Caplan; Olivia Ben-Levy; Abigail C Neininger; Dylan T Burnette; Vincent Q Trinh; Marcus C B Tan; Emilee A Patterson; Rafael Arrojo E Drigo; Rajshekhar R Giraddi; Cynthia Ramos; Anna L Means; Ichiro Matsumoto; Uri Manor; Jason C Mills; James R Goldenring; Ken S Lau; Geoffrey M Wahl; Kathleen E DelGiorno
Journal:  Gastroenterology       Date:  2021-10-23       Impact factor: 22.682

Review 5.  Diabetes and Pancreatic Cancer-A Dangerous Liaison Relying on Carbonyl Stress.

Authors:  Stefano Menini; Carla Iacobini; Martina Vitale; Carlo Pesce; Giuseppe Pugliese
Journal:  Cancers (Basel)       Date:  2021-01-16       Impact factor: 6.639

Review 6.  Post-pancreatitis diabetes mellitus and excess intra-pancreatic fat deposition as harbingers of pancreatic cancer.

Authors:  Maxim S Petrov
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

7.  Temporality of clinical factors associated with pancreatic cancer: a case-control study using linked electronic health records.

Authors:  Abu Z M Dayem Ullah; Konstantinos Stasinos; Claude Chelala; Hemant M Kocher
Journal:  BMC Cancer       Date:  2021-11-27       Impact factor: 4.430

Review 8.  The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular.

Authors:  Junyuan Deng; Yujie Guo; Jiali Du; Jichun Gu; Lei Kong; Boan Tao; Ji Li; Deliang Fu
Journal:  Front Cell Dev Biol       Date:  2022-02-17

9.  Imaging of the Pancreas in New-Onset Diabetes: A Prospective Pilot Study.

Authors:  Bechien U Wu; Eva Lustigova; Qiaoling Chen; Elizabeth Y Dong; Anirban Maitra; Suresh T Chari; Ziding Feng; Jo Ann Rinaudo; Lynn M Matrisian; Rex A Parker
Journal:  Clin Transl Gastroenterol       Date:  2022-06-01       Impact factor: 4.396

10.  Systematic review of Mendelian randomization studies on risk of cancer.

Authors:  Georgios Markozannes; Afroditi Kanellopoulou; Olympia Dimopoulou; Dimitrios Kosmidis; Xiaomeng Zhang; Lijuan Wang; Evropi Theodoratou; Dipender Gill; Stephen Burgess; Konstantinos K Tsilidis
Journal:  BMC Med       Date:  2022-02-02       Impact factor: 11.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.